PB/PK
ML and AI can revolutionise the way we do PB/PK.
PB/PK faces three key challenges:
Conversion from animal models to humans
Lack of suitability for cutting-edge treatments
Our approach
We use cutting-edge AI techniques to solve these problems.
- Combining kinetics, thermodynamics, and neural networks allows us to reduce the parameter space and perform in low-data environments.
- Our neural nets learn how animal models generalise to humans, helping bridge the gap.
- The flexible, modular design we use allows us to easily adapt our models to any drug. Nanoparticles, mABs, peptides, and anything else can all be modelled with our network design.
Find out how we can solve your PB/PK problems.